Terms ending in 2041
Every in-force patent on Emory University's record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,939,593 | Compositions and Methods for Improving Embryo Development In force · High confidence | University of Georgia Research Foundation, Inc. | In force | High confidence | |
| US 11,542,548 | Blood DNA Methylation Biomarker Diagnostic Test for Anxiety and Depressive Disorders In force · High confidence | Emory University | In force | High confidence | |
| US 11,964,109 | Systems and Methods for Driving Neural Activity to Control Brain Signaling and Gene Expression In force · High confidence | Emory University | In force | High confidence | |
| US 12,098,180 | Compositions and Uses of Vasoactive Intestinal Peptide (VIP) Antagonists In force · High confidence | Emory University | In force | High confidence | |
| US 12,357,629 | Uses of Bcl-2 Antagonists for Treating Cancer and Diagnostics Related Thereto In force · High confidence | Emory University | In force | High confidence | |
| US 12,269,864 | Self-Assembling Collagen-Like Polypeptides for Applications and Uses Related Thereto In force · High confidence | Emory University | In force | High confidence | |
| US 11,943,940 | Nucleic Acid-Based Electrically Readable, Read-Only Memory In force · High confidence | The Regents of the University of California | In force | High confidence | |
| US 11,963,675 | Orthopedic Fixation Devices and Methods In force · High confidence | Emory University | In force | High confidence | |
| US 11,857,618 | Boosting Immunogenicity of Vaccines Using Saponins and Agonists of the Intracellular Stimulator of Interferon Genes Pathway In force · High confidence | Emory University | In force | High confidence | |
| US 11,648,221 | KRAS Agonists, Pharmaceutical Compositions, and Uses in Managing Cancer In force · High confidence | Emory University | In force | High confidence | |
| 13 more term ends in 2041 · Pro | |||||
10 of 23 patents shown. Soonest term end first, then patent number.
Pro members see all 23.
18 of these are in force and held by Emory University.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.